Daily as of 2 Nov 16:00 ET
- Price
- above both $9.85 vs 50 $9.60 / 200 $8.59
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 7 Oct 2026 · projected 22 bars out
DNA | Ginkgo Bioworks HoldingsNYSEHealthcareCommon stock golden cross and death cross projections, cross tests and history
$9.85
-$1.36 (-12.13%)
Ginkgo Bioworks Holdings (DNA) is a NYSE-listed common stock that Cruxta has tracked for 50/200 crosses since 2023.
The 50 SMA has sat above the 200 on the daily since Oct 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the weekly and the 4-hour, price sits between the 50 and the 200; on the daily it is above both.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- between the two $11.21 vs 50 $8.61 / 200 $28.01
- Projection
- No cross projected
- Test
- No active test
- Last cross
- No cross on record
4-hour as of 3 Nov 16:00 ET
- Price
- between the two $10.76 vs 50 $11.46 / 200 $9.04
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 2 Oct 2026 · projected 27 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 7 Oct 2026 | 🟨Golden moderate | daily | 22 bars out | Not tested |
| 2 Oct 2026 | 🟨Golden | 4-hour | 27 bars out | Not tested |
| 31 Aug 2026 | 💀Death moderate | daily | 7 bars out | Not tested |
| 19 Aug 2026 | 🟨Golden flat | daily | not projected | Not tested |
| 17 Aug 2026 | 💀Death flat | daily | 30 bars out | Not tested |
About DNA
ExchangeNYSE
InstrumentCommon stock
Median $ volume, 60 d$13.5M
4-hour coverageYes, since Oct 2025
History on recordSince 2023
SectorHealthcare
Cap bandsmall